Table 1.
NSAF ratio |
fractional turnover rate (%/h) |
RPR ratio |
||||
---|---|---|---|---|---|---|
accession | name of protein | molecular function | WD/ SD |
SD | WD | WD/ SD |
Complement/Immune Response | ||||||
218156289 | complement factor B isoform 1 precursor | serine-type endopeptidase | 1.59 | 10.79 ± 1.07 | 11.29 ± 1.89 | 1.66c |
568966398 | complement factor D isoform X1 | serine-type endopeptidase | 0.54 | 3.72 ± 0.03 | 3.22 ± 0.03b | 0.46c |
109627652 | complement factor H precursor | C3b binding | 0.81 | 4.43 ± 0.22 | 5.57 ± 0.28b | 1.02 |
568921715 | complement factor I isoform X3 | complement activation | 0.88 | 5.21 ± 1.04 | 6.22 ± 0.72 | 1.05 |
114326449 | properdin precursor (factor P) | complement activation | 1.26 | 2.11 ± 0.26 | 0.71 ± 0.07b | 0.43c |
126518317 | complement C3 precursor | endopeptidase inhibitor | 0.67a | 11.92 ± 1.63 | 11.91 ± 1.69 | 0.67c |
6754164 | complement C5 preproprotein | endopeptidase inhibitor | 1.81 | 4.02 ± 0.45 | 3.96 ± 0.80 | 1.79c |
161086891 | complement component 6 precursor | immune response | 1.72 | 5.52 ± 0.57 | 6.53 ± 0.43b | 2.03c |
345110552 | complement component C7 precursor | immune response | 0.76 | 1.49 ± 0.16 | 1.67 ± 0.05 | 0.85 |
22122667 | complement component C8 alpha chain isoform 1 precursor |
complement activation | 1.51 | 4.90 ± 0.22 | 4.19 ± 0.22 | 1.55 |
15375312 | complement component C9 precursor | complement activation | 1.81 | 6.59 ± 0.73 | 7.60 ± 0.49b | 2.09c |
568986620 | clusterin isoform X2 (ApoJ) | misfolded protein binding | 1.04 | 12.40 ± 1.25 | 14.63 ± 1.63b | 1.23 |
Antioxidants | ||||||
261823995 | serum paraoxonase/arylesterase 1 precursor | antioxidant | 0.67 | 1.54 ± 0.20 | 1.44 ± 0.23 | 0.63c |
15011841 | glutathione peroxidase 3 precursor | antioxidant | 0.65 | 2.23 ± 0.24 | 2.50 ± 0.53 | 0.73 |
Lipid Metabolism | ||||||
160333304 | apolipoprotein A-I preproprotein | cholesterol transporter | 0.68a | 4.64 ± 0.42 | 4.92 ± 0.45 | 0.72c |
157951676 | apolipoprotein A-II precursor | cholesterol transporter | 1.18 | 5.58 ± 0.62 | 4.12 ± 0.32b | 0.87 |
244791354 | phosphatidylcholine-sterol acyltransferase | phosphatidylcholine-sterol O- acyltransferas |
1.03 | 5.76 ± 0.80 | 5.08 ± 0.46 | 1.36 |
568915857 | phospholipid transfer protein isoform X1 | lipid binding | 1.96 | 2.90 ± 0.51 | 3.63 ± 1.14 | 2.46c |
158517825 | apolipoprotein C-I precursor | fatty acid binding | 1.51 | 6.92 ± 0.95 | 7.84 ± 0.81 | 1.34 |
577019552 | apolipoprotein C-III isoform a | lipid binding | 0.84 | 6.59 ± 0.06 | 6.80 ± 0.99 | 0.87 |
110347473 | apolipoprotein A-IV precursor | antioxidant, cholesterol transporter | 1.21 | 8.34 ± 0.79 | 12.10 ± 0.71b | 1.75c |
163644329 | apolipoprotein E precursor | antioxidant, cholesterol transporter | 1.59 | 11.81 ± 1.09 | 13.25 ± 0.70b | 1.79c |
75677437 | apolipoprotein D precursor | cholesterol binding | 0.73 | 2.64 ± 0.13 | 2.79 ± 0.01 | 0.77 |
163310765 | serum albumin precursor | DNA binding | 0.78 | 0.80 ± 0.21 | 1.29 ± 0.36b | 1.25c |
7305599 | transthyretin precursor | hormone binding | 0.54a | 6.64 ± 0.10 | 6.02 ± 0.49 | 0.49c |
Vitamin Transport | ||||||
125347464 | afamin precursor | vitamin E binding | 0.79 | 1.54 ± 0.23 | 3.63 ± 0.42b | 1.87c |
51172612 | vitamin D-binding protein precursor | actin binding | 0.83 | 6.95 ± 1.16 | 11.57 ± 0.92b | 1.38c |
33859612 | retinol-binding protein 4 isoform 1 | retinol binding | 1.13 | 11.19 ± 1.33 | 17.63 ± 0.75 | 1.79 |
Acute Phase Response | ||||||
76881807 | alpha-1-antitrypsin 1–2 precursor | serine-type endopeptidase inhibitor | 0.71a | 3.72 ± 0.65 | 3.07 ± 0.37b | 0.59c |
7304875 | alpha-2-HS-glycoprotein isoform 1 (Fetuin A) | cysteine-type endopeptidase inhibitor | 0.83 | 6.71 ± 0.78 | 7.21 ± 0.35 | 0.89 |
6755398 | serum amyloid A-4 protein precursor | acute-phase response | 0.50 | 6.55 ± 0.44 | 5.82 ± 0.22b | 0.45c |
110347564 | ceruloplasmin isoform b precursor | copper ion binding | 0.93 | 5.57 ± 0.65 | 6.41 ± 0.75 | 1.07 |
449083336 | fibronectin isoform b precursor | peptidase activator | 2.74a | 4.16 ± 0.55 | 4.12 ± 0.48 | 2.74c |
6753798 | prothrombin precursor | thrombospondin receptor | 0.87 | 5.27 ± 0.54 | 8.53 ± 1.39 | 1.41c |
156231029 | kininogen 2 isoform 2 precursor | serine-type endopeptidase inhibitor | 0.39a | 4.12 | 10.97 ± 1.64 | 0.41 |
160358829 | hemopexin precursor | metal ion binding | 1.24 | 2.99 ± 0.38 | 4.62 ± 0.40b | 1.92c |
8850219 | haptoglobin precursor | hemoglobin binding | 2.45 | 8.50 ± 1.11 | 23.04 ± 2.25b | 13.27c |
Immune Response | ||||||
568999092 | H-2 class I histocompatibility antigen, Q10 alpha chain isoform X1 |
peptide antigen binding | 0.77 | 2.31 ± 0.09 | 5.66 ± 0.68b | 1.89 |
160415217 | zinc-alpha-2-glycoprotein precursor | peptide antigen binding | 1.31 | 5.84 ± 0.14 | 8.16 ± 0.16b | 1.83c |
170172530 | immunoglobulin J chain precursor | antigen binding | 1.93a | 5.15 ± 0.58 | 1.64 ± 0.01b | 0.61 |
Proteolysis | ||||||
568910406 | antithrombin-III isoform X1 | serine-type endopeptidase inhibitor | 0.52a | 4.53 ± 0.11 | 5.71 ± 0.21b | 0.66 |
257471003 | plasminogen precursor | serine-type endopeptidase | 0.81 | 6.60 ± 0.39 | 6.50 ± 0.30 | 0.80c |
236465805 | plasma kallikrein precursor | serine-type endopeptidase | 1.11 | 2.49 ± 0.25 | 2.52 ± 0.42 | 1.12 |
Proteolysis Inhibition | ||||||
124249351 | interalpha-trypsin inhibitor heavy chain H1 precursor |
serine-type endopeptidase inhibitor | 0.62 | 5.45 ± 0.40 | 4.77 ± 0.53 | 0.55c |
226874935 | interalpha-trypsin inhibitor heavy chain H2 precursor |
serine-type endopeptidase inhibitor | 0.38a | 3.90 ± 0.31 | 4.21 ± 0.58 | 0.41c |
Proteolysis Inhibition | ||||||
159110717 | interalpha-trypsin inhibitor heavy chain H3 precursor |
serine-type endopeptidase inhibitor | 1.45 | 5.86 ± 1.26 | 6.82 ± 0.11 | 1.69 |
148747546 | serine protease inhibitor A3K precursor | serine-type endopeptidase inhibitor | 0.76a | 3.33 ± 0.54 | 3.50 ± 0.33 | 0.80 |
130503301 | serine protease inhibitor A3N precursor | serine-type endopeptidase inhibitor | 1.15 | 1.97 ± 0.32 | 2.87 ± 0.57b | 1.39 |
31982171 | murinoglobulin-1 precursor | serine-type endopeptidase inhibitor | 0.94 | 2.67 ± 0.52 | 2.11 ± 0.31 | 0.75c |
Metal Binding | ||||||
20330802 | serotransferrin precursor | ferric iron binding | 0.80 | 2.61 ± 0.35 | 2.62 ± 0.37 | 0.80c |
17647499 | hemoglobin subunit beta-2 | heme binding | 2.44a | 0.13 ± 0.01 | 0.21 ± 0.02b | 3.85 |
226958456 | histidine-rich glycoprotein precursor | cysteine-type endopeptidase inhibitor |
1.28 | 2.49 ± 0.27 | 2.37 ± 0.38 | 1.21 |
Hemostasis | ||||||
110347469 | alpha-2-macroglobulin precursor | endopeptidase inhibitor | 0.83a | 2.18 ± 0.29 | 2.21 ± 0.28 | 0.84c |
110625994 | coagulation factor X isoform 2 preproprotein | calcium ion binding | 3.58a | 5.65 ± 0.78 | 5.17 ± 0.86 | 3.27c |
Other Plasma Proteins | ||||||
111378397 | phosphatidylinositol-glycan-specific phospholipase D precursor |
phospholipase D | 0.78 | 3.42 ± 0.28 | 3.06 ± 0.06 | 0.70c |
28916693 | gelsolin isoform 1 precursor | metal ion binding | 0.79 | 6.52 ± 1.03 | 4.58 ± 0.73b | 0.55c |
16418335 | leucine-rich alpha-2-glycoprotein precursor | transforming growth factor beta receptor binding |
0.99 | 4.07 ± 0.10 | 6.57 ± 0.30b | 1.59 |
Significant difference in NSAF (P < 0.05).
Significant difference in k (P < 0.05).
Significant difference in RPR (P < 0.05).